QIAGEN (QGEN) has traded above the average analyst 12-month target price of $41.47, last changing hands at $41.99 (+$0.52). The move suggests the stock is now meeting the market’s upside expectations, though the article notes analysts may respond with either a valuation-related downgrade or an updated stance.
QIAGEN (QGEN) has traded above the average analyst 12-month target price of $41.47, last changing hands at $41.99 (+$0.52). The move suggests the stock is now meeting the market’s upside expectations, though the article notes analysts may respond with either a valuation-related downgrade or an updated stance.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
